Quebec CBD 20-1

Cannabis Strain by Quebec Cannabis Seeds

Introduction
Quebec CBD 20-1 from Quebec Cannabis Seeds represents Canadian breeding focused on high-CBD, low-THC genetics for medical applications. The "20-1" designation indicates an approximately 20:1 ratio of CBD to THC—meaning patients can access cannabidiol's therapeutic properties while experiencing minimal psychoactive effects. At 63 days flowering, this mostly-indica expression sits in standard territory for worked medical genetics.

Lineage
Quebec Cannabis Seeds positions themselves as comprehensive online market for varied marijuana seed types, including regular, autoflowering, feminized, and CBD-focused genetics. Their Canadian location reflects the country's progressive cannabis policies and growing medical market requiring diverse cannabinoid profiles beyond purely recreational THC-focused strains.

Terpenes
Terpene profiles in CBD-dominant strains typically emphasize myrcene, beta-caryophyllene, and pinene—producing earthy, spicy, herbal aromatics rather than the fruity or dessert flavors popular in recreational breeding. These terpenes contribute to therapeutic effects through the entourage effect, where cannabinoids and terpenes work synergistically.

Growth
Cultivation follows mostly-indica patterns: compact structure, manageable height, dense flowers. The 63-day flowering accommodates most growing situations. CBD plants typically grow vigorously with good yields, making medical production commercially viable.

Effects
Effects focus on therapeutic territory: potential anti-inflammatory, anxiolytic, and pain management properties without significant psychoactive experience. The 20:1 ratio means users experience CBD's effects while THC remains below psychoactive thresholds for most individuals.

Documentation
Quebec Cannabis Seeds continues operating, serving Canadian medical and recreational markets.

⚠️ This information is for educational purposes only and should not be considered medical advice.

Sources: https://quebeccannabisseeds.com